Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early and intermediate age-related macular degeneration: update and clinical review.

Clinical interventions in aging - 1 Jan 2017

García-Layana Alfredo, Cabrera-López Francisco, García-Arumí José, Arias-Barquet Lluís, Ruiz-Moreno José M

Abstract excerpt

Age-related macular degeneration (AMD) is the leading cause of irreversible central vision loss in developed countries. With the aging of population, AMD will become globally an increasingly important and prevalent disease worldwide. It is a complex disease whose etiology is associated with both genetic and environmental risk factors. An extensive decline in the quality of life and progressive need of daily...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antioxidants
Share to Diet, Healthy
Share to Dietary Supplements

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Health Behavior

Share to Macular Degeneration

Share to Quality of Life

Share to Smoking Cessation

Source

Open in PubMed Open full text

Identifiers

PMID: 29042759
DOI: 10.2147/CIA.S142685
PMCID: PMC5633280

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early and intermediate age-related macular degeneration: update and clinical review.PMID 29042759Read ↗

Mechanisms of age-related macular degeneration and therapeutic opportunities.Semantic proximity Read ↗

Age‐related macular degeneration—clinical review and genetics updateSemantic proximity Read ↗

Incidence of and Risk Factors Associated With Age-Related Macular Degeneration: Four-Year Follow-up From the ALIENOR Study.Semantic proximity Read ↗

The genetics of age-related macular degeneration (AMD)--Novel targets for designing treatment options?Semantic proximity Read ↗

[Risk factors for age-related macular degeneration : Lessons learned from current data].Semantic proximity Read ↗

Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis.Semantic proximity Read ↗

Recent Advances in Proteomic-based Approaches to Study Age-related Macular Degeneration: A Systematic ReviewSemantic proximity Read ↗

Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factorsSemantic proximity Read ↗

Age-Related Macular Degeneration: Role of Oxidative Stress and Blood VesselsSemantic proximity Read ↗

Macular degeneration: recent advances and therapeutic opportunities.Semantic proximity Read ↗

Age-Related Macular Degeneration: Cellular and Molecular Signaling MechanismsSemantic proximity Read ↗

Molecular Genetic Mechanisms in Age-Related Macular Degeneration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.